Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription

Journal of Lipid Research

Volumn 43, Issue 12, 2002, Pages 2172-2179

  Raspé, Eric ^a,b   Duez, Hélène ^a   Mansén, Anethe ^c   Fontaine, Coralie ^a   Fiévet, Catherine ^a   Fruchart, Jean Charles ^a,d   Vennström, Bjorn ^c   Staels, Bart ^a,d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b Centre de Recherche et Developpement   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIV LILLE   (France)

Author keywords

Apolipoprotein C III; Nuclear receptors; Triglycerides

Indexed keywords

APOLIPOPROTEIN C3; CELL NUCLEUS RECEPTOR; LIPID; MESSENGER RNA; PROTEIN REV ERBALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN C; CELL RECEPTOR; DNA BINDING PROTEIN; NR1D1 PROTEIN, HUMAN; NR1D1 PROTEIN, MOUSE; NR1D1 PROTEIN, RAT; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE MAPPING; KIDNEY CELL; LIPID METABOLISM; LIVER CELL; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RISK FACTOR; TATA BOX; TRANSCRIPTION REGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CHOLESTEROL, VLDL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; MALE; MICE; MICE, INBRED BALB C; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0036906591     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200386-JLR200     Document Type: Article

References (46)

1. Hodis H. N. 1999. Triglycerides-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation. 99:2852-2854.
2. Krauss, R. M. 1998. Atherogenicity of triglyceride-rich lipoproteins. Am. J. Cardiol. 81: 13B-17B.
3. Assmann, G., P. Cullen, and H. Schoulte. 1998. The Muster Heart Study (PROGRAM). Results of follow-up at 8 years. Eur Heart J. 19 (Suppl):A2-11.
4. Davignön, J., and J. S. Cohn. 1996. Triglycerides: A risk factor for coronary heart disease. Atherosclerosis. 124(Suppl):S57-64.
5. Gotto, A. M., Jr. 1998. Triglyceride: The forgotten risk factor. Circulation. 97: 1027-1028.
6. Hokanson, J. E., and M. A. Austin. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3: 213-219.
7. Shachter, N. S. 2001. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 12: 297-304.
8. Jong, M. C., M. H. Hofker, and L. M. Havekes. 1999. Role of ApoCs in lipoprotein metabolism: Functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
9. Chen, M., J. L. Breslow, W. Li, and T. Leff. 1994. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels. J. Lipid. Res. 35: 1918-1924.
10. Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L., Brcslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apoC-III gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
11. Lin-Lee, Y. C., W. Strobl, S. Soyal, M. Radosavljevic, M. Song, A. M. Gotto, Jr., and W. Patsch. 1993. Role or thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver. J. Lipid Res. 34: 249-259.
12. Lacorte, J. M., E. Ktistaki, A. Beigneux, V. I. Zannis, J. Chambaz, and I. Talianidis. 1997. Activation of CAAT enhancer-binding protein delta (C/EBPdelta) by interleukin-1 negatively influences apolipoprotein C-III expression. J. Biol. Chem. 272: 23578-23584.
13. Lacorte, J. M., A. Beigneux, M. Parant, and J. Chambaz. 1997. Repression of apoC-III gene expression by TNFalpha involves C/EBPdelta/NF-IL6beta via an IL-1 independent pathway. FEBS Lett. 415: 217-220.
14. Hanbenwallner, S., A. D. Essenhurg, B. C. Barnett, M. E. Pape, R. B. DeMattos, B. R. Krause, L. L. Minton, B. J. Auerhach, R. S. Newton, T. Leff, and C. L.Bisgaier. 1995. Hypolipidemic activity of select-fibrates correlates to changes in hepatic apolipoprotein C-III expression: A potential psychologic basis for their mode of action. J. Lipid Res. 36: 2541-2551.
15. Staels, B., N. Vu-Dac, V. A. Kosykh, R. Saladin, J. C. Fruchart, Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
16. Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-IIl. J. Biol Chem. 270: 13470-13475.
17. Raspé, E., L. Madsen, A. M. Lefebvre, I. Leitersdorf, L.Gelman J. Peinado-Onsurbe, J. Dallongeville, J. C. Fruchart, R. Berge, and B. B. Staels. 1999. Modulation of rat liver apolipoprotein gene expression and serum lipid levels hy tetradecylthioacetic acid (TTA) via PPARalpha activation. J. Lipid Res. 40: 2099-2110.
18. Vu-Dac, N., P. Gervois, I. P. Torra, J. C. Fruchart, V. Kosykh, T. Kooistra, H. M. Princen, J. Dallongeville, and B. Staels. 1998. Retinoids increase human apoC-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J. Clin. Invest. 102: 625-632.
19. Karaihanasis, S. K. 1985. Apolipoprotein multigene family: Tandem organization of human apolipoprotein A, C-III, and AIV genes. Proc. Natl. Acad. Sci. USA. 82: 6374-6378.
20. Zannis, V. I., H. Y. Kan, A. Kritis, E. E. Zanni, and D. Kardassis. 2001. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Curr. Opin. Lipidol. 12: 181-207.
21. Raspé, E., H. Duez, P. Gervois, C. Fieve, J. C. Fruchart, S. Besnard, J. Mariani, A. Tedgui, and B. Staels. 2001. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J. Biol. Chem. 276: 2865-2871.
22. Pastier, D., J. M. Lacorte, J. Chambaz, P. Cardot, and A. Ribeiro. 2002. Two initiator-like elements are reqired for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic factor-4. J. Biol. Chem. 277: 15199-15206.
23. Giguere, V. 1999. Orphan nuclear receptors: From gene to function. Endocr. Rev. 20: 689-725.
24. Miyajima, N., R. Horiuchi, Y. shibuya, S. Fukushige, K. Matsuhara, K. toyoshima, and Y. Yamamoto. 1989. Two erbA homologs encoding protiens with diferent T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell. 57: 31-39.
25. Lazar, M. A., R. A. Hodin, D. S. Darling, and W. W. Chin. 1989. A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA alpha transcriptional unit. Mol. Cell. Biol. 9: 1128-1136.
26. Laudet, V., A. Begue, C. Henry-Duthoit, A. Joubel, P. Martin, D. Stehelin, and S. Saule. 1991. Genomic organization of the human thyroid hormone receptor alpha (c-erbA-1) gene. Nucliec Acids Res. 19: 1105-1112.
27. Harding, H. P., and M. A. Lazar. 1995. The orphan receptor Rev-ErbA alpha activates transcription via a novel response element. Mol Cell. Biol. 13: 3113-3121.
28. Harding, H. P., and M. A. Lazar. 1995. The monomer-binding orphan receptor Rev-ErB represses transcription as a dimer on a novel direct repeat. Mol. Cell. Biol. 15: 4791-4802.
29. Forman, B. M., J. Chen, B. Blumberg, S. A. Kliewer, R. Henshaw, E. S. Ong, and R. M. Evans. 1994. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol. Endocrinol. 8: 1253-1261.
30. Adelmant, G., A. Begue, D. Stahelin, and V. Laudet. 1996. A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity. Proc. Natl. Acad. Sci. USA. 93: 3553-3558.
31. Gervois, P., S. Chopin-Delannoy, A. Fadel, G. Dubois, V. Kosykh, J. C. Fruchart, J. Najib, V. Laudet, and B. Staels. 1999. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element. Mol. Endocrinol. 13: 400-409.
32. Torra, I. P., V. Tsibulsky, F. Delaunay, R. Saladin, V. Laudet, J. C. Fruchart, V. Kosykh, and B. Staels. 2000. Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver. Endocrinology. 141: 3799-3806.
33. Downes, M., A.J. Carozzi, and G. E. Muscat. 1995. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol. Endocrinol. 9: 1666-1678.
34. Dussault, I., and V. Giguere. 1997. Differential regulation of the N-myc proto-oncogene by ROR alpha and RVR, two orphan members of the superfamily of nuclear hormone receptors. Mol. Cell. Biol. 17: 1860-1867.
35. Kassam, A., J. P. Capone, and R. A. Rachubinski. 1999. Orphan nuclear hormone receptor RevErbalpha modulates expression from the promoter of the hydratase-dehydrogenase gene by inhibiting peroxisome proliferator-activated receptor alpha-dependent transactivation. J. Biol. Chem. 274: 22895-22900.
36. Bois-Joyeux B., C. Chauvet, H. Nacer-Cherif, W. Bergeret, N. Mazure, V. Giguere, V. Laudet, and J. L. Danan. 2000. Modulation of the farupstream enhancer of the rat alpha-fetoprotein gene by members of the ROR alpha, Rev-erb alpha, and Rev-erb beta groups of monomeric orphan nuclear receptors. DNA Cell. Biol. 19: 589-599.
37. Vu-Dac, N., S. Chopin-Delannoy, P. Gervois, E. Bonnelye, G. Martin, J. C. Fruchart, V. Laudet, and B. Staels. 1998. The nuclear receptors peroxisome proliferator-activated receptor alpha and Reverbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 273: 25713-25720.
38. Chomez, P., I. Neveu, A. Mansen, E. Kiesler, L. Larsson, B. Vennstrom, and E. Arenas. 2000. Increased cell death and delayed development in the cerebellum of mice lacking the rev-erbA(alpha) orphan receptor. Development. 127: 1489-1498.
39. Coste, H., and J. C. Rodriguez. 2002. Orphan nuclear hormone receptor rev-erbalpha regulates the human apolipoprotein C-III promoter. J. Biol. Chem. 277: 27120-27129.
40. Schoonjans, K., J. Peinade-Onsurbe, J. C. Fruchart, A. Tailleux, C. Fievet, and J. Auwerx. 1999. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase. FEBS Lett 452: 160-164.
41. Peters, J. M., N. Hennuyer, B. Staels, J. C. Fruchart, C. Fievet, F. J. Gonzalez, and J. Auwerx. 1997. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem. 272: 27307-27312.
42. Januzzi, J. L., N. Azrolan, A. O'Connell, K. Allto-tala, and J. L. Breslow. 1992. Characterization oftbe mouse apolipoprotein Apoa-1/Apoc-3 gene locus: Genomic, mRNA, and protein sequences with comparisons to other species. Genomics. 14: 1081-1088.
43. Goto, A., H. Pownall, and R. J. Havel. 1986. Introduction to plasma lipoproteins. Methods Enzymol. 128: 3-41.
44. Stein, O., and Y. Stein. 1999. Atheroprotective mechanisms of HDL. Atherosclerosis. 144: 285-301.
45. Vu-Dac, N., P. Gervois, T. Grotzinger, P. De Vos, K. Schoonjans, J. C. Fruchart, J. Auwerx, J. Mariani, A. Tedgui, and B. Staels. 1997. Transcriptional regulation of apolipoprotein A-1 gene expression by the nuclear receptor RORalpha. J. Biol. Chem. 272: 22401-22404.
46. Mamontova, A., S. Seguret-Mace, B. Esposito, C. Chaniale, M. Bouly, N. Delhaye-Bouchaud, G. Luc, B. Staels, N. Duverger, J. Mariani, and A. Tedgui. 1998. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation. 98: 2788-2743.